Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
- DOI
- 10.1016/j.ebiom.2023.104481
- Published
- 2023-04
- Container
- eBioMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2023.104481,
title = {Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability},
author = {Anoop Nambiar and Dean Kellogg and Jaime Justice and Martin Goros and Jonathan Gelfond and Rodolfo Pascual and Shahrukh Hashmi and Michal Masternak and Larissa Prata and Nathan LeBrasseur and Andrew Limper and Stephen Kritchevsky and Nicolas Musi and Tamara Tchkonia and James Kirkland},
year = {2023},
journal = {eBioMedicine},
doi = {10.1016/j.ebiom.2023.104481},
url = {https://doi.org/10.1016/j.ebiom.2023.104481}
}RIS
TY - JOUR TI - Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability AU - Anoop Nambiar AU - Dean Kellogg AU - Jaime Justice AU - Martin Goros AU - Jonathan Gelfond AU - Rodolfo Pascual AU - Shahrukh Hashmi AU - Michal Masternak AU - Larissa Prata AU - Nathan LeBrasseur AU - Andrew Limper AU - Stephen Kritchevsky AU - Nicolas Musi AU - Tamara Tchkonia AU - James Kirkland PY - 2023 JO - eBioMedicine DO - 10.1016/j.ebiom.2023.104481 UR - https://doi.org/10.1016/j.ebiom.2023.104481 ER -
APA
Nambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., Limper, A., Kritchevsky, S., Musi, N., Tchkonia, T., & Kirkland, J. (2023). Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. eBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104481
Source records
- crossref · retrieved 2026-09-26T13:14:23.297Z